COMPASS: Rivaroxaban Reduces CV and Limb Events in PAD COMPASS: Rivaroxaban Reduces CV and Limb Events in PAD

The combination of low-dose rivaroxaban plus aspirin has become the first drug regimen to show a clear-cut reduction in both cardiovascular and limb events, including amputations, in patients with peripheral arterial disease.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news